Form 8-K - Current report:
SEC Accession No. 0001193125-26-183711
Filing Date
2026-04-28
Accepted
2026-04-28 08:30:32
Documents
15
Period of Report
2026-04-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d153155d8k.htm   iXBRL 8-K 45487
2 EX-4.1 d153155dex41.htm EX-4.1 76727
3 EX-10.1 d153155dex101.htm EX-10.1 277860
4 EX-10.2 d153155dex102.htm EX-10.2 127527
5 EX-99.1 d153155dex991.htm EX-99.1 10177
  Complete submission text file 0001193125-26-183711.txt   782965

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA clym-20260427.xsd EX-101.SCH 3168
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE clym-20260427_lab.xml EX-101.LAB 18735
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clym-20260427_pre.xml EX-101.PRE 11699
18 EXTRACTED XBRL INSTANCE DOCUMENT d153155d8k_htm.xml XML 3766
Mailing Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481
Business Address 20 WILLIAM STREET SUITE 145 WELLESLEY HILLS MA 02481 1-866-857-2596
Climb Bio, Inc. (Filer) CIK: 0001768446 (see all company filings)

EIN.: 832273741 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40708 | Film No.: 26903291
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)